8 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 19567819 | Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors. | 2009 Jul | 1 |
2 | 17043649 | Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition. | 2007 Apr 12 | 3 |
3 | 17929114 | The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias. | 2007 Oct | 1 |
4 | 17076652 | New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. | 2006 Oct | 1 |
5 | 15459011 | A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor. | 2005 Feb 15 | 2 |
6 | 15273685 | Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation. | 2004 Aug | 1 |
7 | 12684394 | A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants. | 2003 Apr | 5 |
8 | 12154026 | Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. | 2002 Aug 1 | 1 |